Tag: Remdesivir

Bhubaneswar: After several states, Odisha is now facing a shortage of Remdesivir injection used in the treatment for COVID-19. Admitting the scarcity in the stocks of the essential medicine, Drugs…

New Delhi: The Union home ministry said several steps have been taken to augment the production and supply of Remdesivir injections from 38.80 lakh units per month to 74 lakh…

New Delhi: Addressing shortages of Remdesivir in certain regions of the country, the Central government on Wednesday made interim allocation of the key anti-viral drug for 19 states/Union Territories for…

New Delhi: Amid surging COVID-19 cases in the country, the government on Tuesday waived customs duty on Remdesivir, its raw materials and other components used to make the antiviral drug.…

New Delhi: Union Home Minister Amit Shah has said that the production of the life saving drug Remdesivir is ‘adequate’ and as a precautionary measure its export has been banned.…

New Delhi: Union Health Minister Harsh Vardhan on Sunday said there will be a 10 times rise in Covaxin vaccine production by September while manufacture of remdesivir jabs, an anti-viral…

Mumbai: Spelling huge relief for lakhs of Covid-19 patients, the government has slashed the prices of the ‘life-saver’ Remdesivir injection by nearly 50 per cent, to MRP Rs 2,450 per…

New Delhi: Drug firm Hetero on Sunday said it has received approval from regulator DCGI to launch investigational antiviral drug Remdesivir for the treatment of COVID-19. Domestic pharma firm Glenmark Pharmaceuticals had on Saturday launched antiviral drug Favipiravir, under the brand name FabiFlu, for the treatment of patients with mild to moderate COVID-19 at a […]

New York: Amid news that the US has bought up virtually the entire global supply of remdesivir, a new study outlines how the drug could save lives in countries with a lower hospital capacity, such as South Africa, where Covid-19 is beginning to overwhelm intensive care units (ICUs). The study, published in the journal Clinical […]

New Delhi: Doctors in state hospitals are being advised to use antiviral Remdesivir on COVID-19 patients strictly as per protocol amid some reports of liver damage in such patients treated with the drug, official sources said. While the health ministry is reviewing the guidelines on the usage of the drug following the adverse reports, states […]

New York: New data revealed by Gilead Sciences has shown that its antiviral drug remdesivir reduces death risk of severe Covid-19 patients by as much as 62 per cent when compared with standard care alone. This is an important finding that requires confirmation in prospective clinical trials, Gilead said on Friday about the results presented […]

Bengaluru: Global pharmaceutical company Mylan on Monday announced the commercial launch of the generic version of Gilead Sciences’s antiviral drug remdesivir under the brand name ‘DESREM’ in India to address urgent needs amid Covid-19. Available at a price of Rs 4,800 per 100mg vial, the drug costs more than 80 per cent less than the […]

New Delhi: Drug firm Zydus Cadila on Thursday said it has launched Remdesivir under the brand name Remdac, used to treat patients suffering from severe symptoms of COVID-19, in the Indian market. Priced at Rs 2,800 per 100 mg vial, Remdac is the most economical Remdesivir brand in India, Zydus Cadila said in a regulatory […]

Bhubaneswar: The Directorate of Drugs Control, Odisha today allowed the retail sale of Covid-19 drugs Remdesivir and Fevipiravir as per the directives of the Drugs Controller General India (DCGI). However, both the COVID drugs will be sold on certain conditions. DCGI has directed that the Fevipiravir tablets and Remdesivir injectable formulation will be sold under […]

New Delhi: The Supreme Court on Wednesday said the Centre has framed rules on drugs clinical trial and there is also an approval on the use of Remdesivir and Favipiravir as medicines to treat Covid-19. A bench headed by Chief Justice S A Bobde and comprising Justices A S Bopanna and V Ramasubramanian, citing the […]